As of 2026-05-27, the Intrinsic Value of Aarey Drugs and Pharmaceuticals Ltd (524412.BO) is 74.12 INR. This 524412.BO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 84.20 INR, the upside of Aarey Drugs and Pharmaceuticals Ltd is -12.00%.
The range of the Intrinsic Value is 58.84 - 99.81 INR
Based on its market price of 84.20 INR and our intrinsic valuation, Aarey Drugs and Pharmaceuticals Ltd (524412.BO) is overvalued by 12.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 58.84 - 99.81 | 74.12 | -12.0% |
| DCF (Growth 10y) | 72.76 - 119.53 | 90.46 | 7.4% |
| DCF (EBITDA 5y) | 91.70 - 147.88 | 115.70 | 37.4% |
| DCF (EBITDA 10y) | 90.31 - 149.56 | 114.75 | 36.3% |
| Fair Value | 16.83 - 16.83 | 16.83 | -80.01% |
| P/E | 58.51 - 98.41 | 77.77 | -7.6% |
| EV/EBITDA | 40.59 - 99.18 | 69.61 | -17.3% |
| EPV | 6.40 - 11.52 | 8.96 | -89.4% |
| DDM - Stable | 15.17 - 28.47 | 21.82 | -74.1% |
| DDM - Multi | 48.41 - 72.40 | 58.16 | -30.9% |
| Market Cap (mil) | 1,968.99 |
| Beta | |
| Outstanding shares (mil) | 23.38 |
| Enterprise Value (mil) | 2,142.84 |
| Market risk premium | 6.92% |
| Cost of Equity | 15.09% |
| Cost of Debt | 19.15% |
| WACC | 14.96% |